Additional information was added to b5, d10, h3, h4 and h6.B5: the customer reported there were a total of 2,102 nonconforming units (previously reported a quantity of up to seven hundred (700) syringes).H4: device manufactured in march 2020.H10: five (5) devices were received for evaluation.The remaining 2,097 were not received and therefore could not be evaluated.Unaided eye visual inspection was done on the returned samples which observed smeared print at the 3.2 ml / 3.3 ml graduation area of samples 1 through 4 and missing print at the 2.5 ml graduation area of sample 5.No functional testing was performed for this complaint.The reported condition was verified.The cause of the condition was determined to be due to a supplier manufacturing issue.A batch review was conducted and during manufacturing, ink spots were found on the cylinders.To correct this issue, two bags were discarded after inspection.This issue is being further investigated.Should additional relevant information become available, a supplemental report will be submitted.
|